FGF23-klotho axis as predictive factors of fractures in type 2 diabetics with early chronic kidney disease

Detalhes bibliográficos
Autor(a) principal: Ribeiro, Ana Luisa
Data de Publicação: 2020
Outros Autores: Mendes, Filipa, Carias, Eduarda, Rato, Fátima, Santos, Nélio, Neves, Pedro Leão, Silva, Ana Paula
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.1/13530
Resumo: Background: The aim of our study was to evaluate the relevance of FGF23-klotho axis in the predisposition for bone fractures in type 2 diabetic patients with early chronic kidney disease. Methods: In a prospective study we included 126 type 2 diabetic patients with CKD stages 2-3 (from 2010 to 2017). We used descriptive statistics, ANOVA and chi-square test. Our population was divided into two groups according to the occurrence of a bone fracture event or not, and the groups were compared considering several biological and laboratorial parameters. We employed a multiple regression model to identify risk factors for bone fracture events and hazard ratios (HR) were calculated using a backward stepwise likelihood ratio (LR) Cox regression. Results: Patients with a fracture event displayed higher levels of FGF-23, Phosphorus, PTH, TNF-alpha, OxLDL, HOMA-IR, calcium x phosphorus product and ACR and lower levels of Osteocalcin, alpha-Klotho, 25(OH)D3 and eGFR compared with patients without a fracture event (p < 0.001). The number of patients with a fracture event was higher than expected within inclining CKD stages (chi 2, p = 0.06). The occurrence of fracture and the levels of TNF-alpha, klotho, 25(OH)D3 and OxLDL were found to predict patient entry into RRT (p < 0.05). Age, osteocalcin, alpha-Klotho and FGF-23 independently influenced the occurrence of bone fracture (p < 0.05). Conclusions: alpha-Klotho and FGF-23 levels may have a good clinical use as biomarkers to predict the occurrence of fracture events. (C) 2019 Elsevier Inc. All rights reserved.
id RCAP_d5d8c4a6ccb6c8e22147e82c023d7aa9
oai_identifier_str oai:sapientia.ualg.pt:10400.1/13530
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling FGF23-klotho axis as predictive factors of fractures in type 2 diabetics with early chronic kidney diseaseBone fractureChronic kidney diseaseDiabetesFGF-23Background: The aim of our study was to evaluate the relevance of FGF23-klotho axis in the predisposition for bone fractures in type 2 diabetic patients with early chronic kidney disease. Methods: In a prospective study we included 126 type 2 diabetic patients with CKD stages 2-3 (from 2010 to 2017). We used descriptive statistics, ANOVA and chi-square test. Our population was divided into two groups according to the occurrence of a bone fracture event or not, and the groups were compared considering several biological and laboratorial parameters. We employed a multiple regression model to identify risk factors for bone fracture events and hazard ratios (HR) were calculated using a backward stepwise likelihood ratio (LR) Cox regression. Results: Patients with a fracture event displayed higher levels of FGF-23, Phosphorus, PTH, TNF-alpha, OxLDL, HOMA-IR, calcium x phosphorus product and ACR and lower levels of Osteocalcin, alpha-Klotho, 25(OH)D3 and eGFR compared with patients without a fracture event (p < 0.001). The number of patients with a fracture event was higher than expected within inclining CKD stages (chi 2, p = 0.06). The occurrence of fracture and the levels of TNF-alpha, klotho, 25(OH)D3 and OxLDL were found to predict patient entry into RRT (p < 0.05). Age, osteocalcin, alpha-Klotho and FGF-23 independently influenced the occurrence of bone fracture (p < 0.05). Conclusions: alpha-Klotho and FGF-23 levels may have a good clinical use as biomarkers to predict the occurrence of fracture events. (C) 2019 Elsevier Inc. All rights reserved.ElsevierSapientiaRibeiro, Ana LuisaMendes, FilipaCarias, EduardaRato, FátimaSantos, NélioNeves, Pedro LeãoSilva, Ana Paula2020-02-18T21:01:28Z20202020-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.1/13530eng1056-8727https://doi.org/10.1016/j.jdiacomp.2019.107476info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-24T10:25:39Zoai:sapientia.ualg.pt:10400.1/13530Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:04:41.123034Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv FGF23-klotho axis as predictive factors of fractures in type 2 diabetics with early chronic kidney disease
title FGF23-klotho axis as predictive factors of fractures in type 2 diabetics with early chronic kidney disease
spellingShingle FGF23-klotho axis as predictive factors of fractures in type 2 diabetics with early chronic kidney disease
Ribeiro, Ana Luisa
Bone fracture
Chronic kidney disease
Diabetes
FGF-23
title_short FGF23-klotho axis as predictive factors of fractures in type 2 diabetics with early chronic kidney disease
title_full FGF23-klotho axis as predictive factors of fractures in type 2 diabetics with early chronic kidney disease
title_fullStr FGF23-klotho axis as predictive factors of fractures in type 2 diabetics with early chronic kidney disease
title_full_unstemmed FGF23-klotho axis as predictive factors of fractures in type 2 diabetics with early chronic kidney disease
title_sort FGF23-klotho axis as predictive factors of fractures in type 2 diabetics with early chronic kidney disease
author Ribeiro, Ana Luisa
author_facet Ribeiro, Ana Luisa
Mendes, Filipa
Carias, Eduarda
Rato, Fátima
Santos, Nélio
Neves, Pedro Leão
Silva, Ana Paula
author_role author
author2 Mendes, Filipa
Carias, Eduarda
Rato, Fátima
Santos, Nélio
Neves, Pedro Leão
Silva, Ana Paula
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Sapientia
dc.contributor.author.fl_str_mv Ribeiro, Ana Luisa
Mendes, Filipa
Carias, Eduarda
Rato, Fátima
Santos, Nélio
Neves, Pedro Leão
Silva, Ana Paula
dc.subject.por.fl_str_mv Bone fracture
Chronic kidney disease
Diabetes
FGF-23
topic Bone fracture
Chronic kidney disease
Diabetes
FGF-23
description Background: The aim of our study was to evaluate the relevance of FGF23-klotho axis in the predisposition for bone fractures in type 2 diabetic patients with early chronic kidney disease. Methods: In a prospective study we included 126 type 2 diabetic patients with CKD stages 2-3 (from 2010 to 2017). We used descriptive statistics, ANOVA and chi-square test. Our population was divided into two groups according to the occurrence of a bone fracture event or not, and the groups were compared considering several biological and laboratorial parameters. We employed a multiple regression model to identify risk factors for bone fracture events and hazard ratios (HR) were calculated using a backward stepwise likelihood ratio (LR) Cox regression. Results: Patients with a fracture event displayed higher levels of FGF-23, Phosphorus, PTH, TNF-alpha, OxLDL, HOMA-IR, calcium x phosphorus product and ACR and lower levels of Osteocalcin, alpha-Klotho, 25(OH)D3 and eGFR compared with patients without a fracture event (p < 0.001). The number of patients with a fracture event was higher than expected within inclining CKD stages (chi 2, p = 0.06). The occurrence of fracture and the levels of TNF-alpha, klotho, 25(OH)D3 and OxLDL were found to predict patient entry into RRT (p < 0.05). Age, osteocalcin, alpha-Klotho and FGF-23 independently influenced the occurrence of bone fracture (p < 0.05). Conclusions: alpha-Klotho and FGF-23 levels may have a good clinical use as biomarkers to predict the occurrence of fracture events. (C) 2019 Elsevier Inc. All rights reserved.
publishDate 2020
dc.date.none.fl_str_mv 2020-02-18T21:01:28Z
2020
2020-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.1/13530
url http://hdl.handle.net/10400.1/13530
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1056-8727
https://doi.org/10.1016/j.jdiacomp.2019.107476
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133284275322880